Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W29427278', 'doi': 'https://doi.org/10.5070/d34vw339w4', 'title': 'Imiquimod 5 percent cream and the treatment of cutaneous malignancy', 'display_name': 'Imiquimod 5 percent cream and the treatment of cutaneous malignancy', 'publication_year': 2004, 'publication_date': '2004-01-01', 'ids': {'openalex': 'https://openalex.org/W29427278', 'doi': 'https://doi.org/10.5070/d34vw339w4', 'mag': '29427278', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/15347486'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.5070/d34vw339w4', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S166925758', 'display_name': 'Dermatology Online Journal', 'issn_l': '1087-2108', 'issn': ['1087-2108'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315571', 'host_organization_name': 'University of California, Davis', 'host_organization_lineage': ['https://openalex.org/P4310316177', 'https://openalex.org/P4310315571'], 'host_organization_lineage_names': ['University of California', 'University of California, Davis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5029969769', 'display_name': 'Daniel Navi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I84218800', 'display_name': 'University of California, Davis', 'ror': 'https://ror.org/05rrcem69', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I84218800']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Daniel Navi', 'raw_affiliation_strings': ['School of Medicine, University of California Davis,,USA'], 'affiliations': [{'raw_affiliation_string': 'School of Medicine, University of California Davis,,USA', 'institution_ids': ['https://openalex.org/I84218800']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5039709057', 'display_name': 'Arthur C. Huntley', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Arthur Huntley', 'raw_affiliation_strings': [], 'affiliations': []}], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 300, 'currency': 'USD', 'value_usd': 300, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 2.308, 'has_fulltext': False, 'cited_by_count': 139, 'citation_normalized_percentile': {'value': 0.933082, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '10', 'issue': '1', 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11306', 'display_name': 'Epidemiology and Management of Skin Cancer', 'score': 0.9937, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11306', 'display_name': 'Epidemiology and Management of Skin Cancer', 'score': 0.9937, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11811', 'display_name': 'Classification and Treatment of Cutaneous Lymphomas', 'score': 0.9894, 'subfield': {'id': 'https://openalex.org/subfields/2708', 'display_name': 'Dermatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10494', 'display_name': 'Viral RNA Silencing and Plant Immunity', 'score': 0.9872, 'subfield': {'id': 'https://openalex.org/subfields/1110', 'display_name': 'Plant Science'}, 'field': {'id': 'https://openalex.org/fields/11', 'display_name': 'Agricultural and Biological Sciences'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/imiquimod', 'display_name': 'Imiquimod', 'score': 0.99625945}, {'id': 'https://openalex.org/keywords/actinic-keratoses', 'display_name': 'Actinic keratoses', 'score': 0.69067806}, {'id': 'https://openalex.org/keywords/imiquimod-cream', 'display_name': 'Imiquimod Cream', 'score': 0.634761}, {'id': 'https://openalex.org/keywords/nucleoside-analogue', 'display_name': 'Nucleoside analogue', 'score': 0.44704583}], 'concepts': [{'id': 'https://openalex.org/C2779112978', 'wikidata': 'https://www.wikidata.org/wiki/Q423417', 'display_name': 'Imiquimod', 'level': 2, 'score': 0.99625945}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9495219}, {'id': 'https://openalex.org/C16005928', 'wikidata': 'https://www.wikidata.org/wiki/Q171171', 'display_name': 'Dermatology', 'level': 1, 'score': 0.7504151}, {'id': 'https://openalex.org/C2910086692', 'wikidata': 'https://www.wikidata.org/wiki/Q422225', 'display_name': 'Actinic keratoses', 'level': 3, 'score': 0.69067806}, {'id': 'https://openalex.org/C2779399171', 'wikidata': 'https://www.wikidata.org/wiki/Q1483951', 'display_name': 'Malignancy', 'level': 2, 'score': 0.45822605}, {'id': 'https://openalex.org/C2777333352', 'wikidata': 'https://www.wikidata.org/wiki/Q2689559', 'display_name': 'Nucleoside analogue', 'level': 3, 'score': 0.44704583}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.34085128}, {'id': 'https://openalex.org/C2776543447', 'wikidata': 'https://www.wikidata.org/wiki/Q28734', 'display_name': 'Nucleoside', 'level': 2, 'score': 0.24506369}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.14869756}, {'id': 'https://openalex.org/C3019992690', 'wikidata': 'https://www.wikidata.org/wiki/Q92767510', 'display_name': 'Basal cell', 'level': 2, 'score': 0.07080737}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C71240020', 'wikidata': 'https://www.wikidata.org/wiki/Q186011', 'display_name': 'Stereochemistry', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000634', 'descriptor_name': 'Aminoquinolines', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D007155', 'descriptor_name': 'Immunologic Factors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D012878', 'descriptor_name': 'Skin Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000634', 'descriptor_name': 'Aminoquinolines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000634', 'descriptor_name': 'Aminoquinolines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D000634', 'descriptor_name': 'Aminoquinolines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000634', 'descriptor_name': 'Aminoquinolines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D017209', 'descriptor_name': 'Apoptosis', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D017209', 'descriptor_name': 'Apoptosis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001913', 'descriptor_name': "Bowen's Disease", 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001913', 'descriptor_name': "Bowen's Disease", 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D002280', 'descriptor_name': 'Carcinoma, Basal Cell', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002280', 'descriptor_name': 'Carcinoma, Basal Cell', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D002294', 'descriptor_name': 'Carcinoma, Squamous Cell', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002294', 'descriptor_name': 'Carcinoma, Squamous Cell', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D045744', 'descriptor_name': 'Cell Line, Tumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D045744', 'descriptor_name': 'Cell Line, Tumor', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D002986', 'descriptor_name': 'Clinical Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003218', 'descriptor_name': 'Condylomata Acuminata', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003218', 'descriptor_name': 'Condylomata Acuminata', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D004354', 'descriptor_name': 'Drug Screening Assays, Antitumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018327', 'descriptor_name': "Hutchinson's Melanotic Freckle", 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018327', 'descriptor_name': "Hutchinson's Melanotic Freckle", 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D000077271', 'descriptor_name': 'Imiquimod', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007111', 'descriptor_name': 'Immunity, Cellular', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007111', 'descriptor_name': 'Immunity, Cellular', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D007155', 'descriptor_name': 'Immunologic Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007155', 'descriptor_name': 'Immunologic Factors', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D007155', 'descriptor_name': 'Immunologic Factors', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D007155', 'descriptor_name': 'Immunologic Factors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D007636', 'descriptor_name': 'Keratoacanthoma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007636', 'descriptor_name': 'Keratoacanthoma', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D007642', 'descriptor_name': 'Keratosis', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D007642', 'descriptor_name': 'Keratosis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008545', 'descriptor_name': 'Melanoma', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D008545', 'descriptor_name': 'Melanoma', 'qualifier_ui': 'Q000556', 'qualifier_name': 'secondary', 'is_major_topic': False}, {'descriptor_ui': 'D008545', 'descriptor_name': 'Melanoma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015337', 'descriptor_name': 'Multicenter Studies as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009182', 'descriptor_name': 'Mycosis Fungoides', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D009182', 'descriptor_name': 'Mycosis Fungoides', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009824', 'descriptor_name': 'Ointments', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010145', 'descriptor_name': 'Paget Disease, Extramammary', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D010145', 'descriptor_name': 'Paget Disease, Extramammary', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011230', 'descriptor_name': 'Precancerous Conditions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011230', 'descriptor_name': 'Precancerous Conditions', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D016032', 'descriptor_name': 'Randomized Controlled Trials as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012878', 'descriptor_name': 'Skin Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.5070/d34vw339w4', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S166925758', 'display_name': 'Dermatology Online Journal', 'issn_l': '1087-2108', 'issn': ['1087-2108'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315571', 'host_organization_name': 'University of California, Davis', 'host_organization_lineage': ['https://openalex.org/P4310316177', 'https://openalex.org/P4310315571'], 'host_organization_lineage_names': ['University of California', 'University of California, Davis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/15347486', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.86}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4387351442', 'https://openalex.org/W4244071458', 'https://openalex.org/W4242300026', 'https://openalex.org/W2485337164', 'https://openalex.org/W2417509913', 'https://openalex.org/W2395239902', 'https://openalex.org/W2198714039', 'https://openalex.org/W2130881659', 'https://openalex.org/W1999472182', 'https://openalex.org/W1979285789'], 'abstract_inverted_index': {'Imiquimod': [0, 41], 'is': [1, 7, 29, 47, 60], 'a': [2, 8, 23, 43, 61], 'novel': [3], 'synthetic': [4], 'compound': [5], 'that': [6], 'member': [9], 'of': [10, 14, 18, 34, 53, 63, 74, 81], 'the': [11, 32, 64, 71], 'imidazoquinolone': [12], 'family': [13], 'drugs.': [15], 'This': [16, 58], 'class': [17], 'drugs,': [19], 'which': [20], 'also': [21], 'includes': [22], 'more': [24], 'potent': [25, 51], 'member,': [26], 'resimiquimod': [27], '(R-848),': [28], 'unique': [30], 'having': [31], 'properties': [33], 'topical': [35], 'immune': [36], 'response': [37], 'modifiers': [38], 'and': [39, 46, 84], 'stimulators.': [40], 'resembles': [42], 'nucleoside': [44], 'analogue': [45], 'known': [48], 'for': [49, 79, 92], 'its': [50, 88], 'induction': [52], 'endogenous': [54], 'antiviral': [55], 'pro-inflammatory': [56], 'mediators.': [57], 'article': [59], 'review': [62], 'relevant': [65], 'literature': [66], 'as': [67], 'it': [68], 'relates': [69], 'to': [70], 'off-label': [72], 'applications': [73], 'imiquimod': [75], '5': [76], 'percent': [77], 'cream': [78], 'treatment': [80], 'cutaneous': [82], 'preneoplastic': [83], 'neoplastic': [85], 'conditions': [86], 'including': [87], 'recently': [89], 'approved': [90], 'indication': [91], 'treating': [93], 'actinic': [94], 'keratoses.': [95]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W29427278', 'counts_by_year': [{'year': 2024, 'cited_by_count': 4}, {'year': 2023, 'cited_by_count': 65}, {'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 6}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 4}, {'year': 2018, 'cited_by_count': 3}, {'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 3}, {'year': 2015, 'cited_by_count': 4}, {'year': 2014, 'cited_by_count': 5}, {'year': 2013, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 2}], 'updated_date': '2024-09-13T06:56:59.408206', 'created_date': '2016-06-24'}